NBIX
NEUROCRINE BIOSCIENCES INC
Company overview
- Market capitalization
- $14.28B
- Employees
- 2,000
- Latest publication
- 2026-09-29
About NEUROCRINE BIOSCIENCES INC
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 959,000,000USD | 814,500,000USD | 805,500,000USD | 794,900,000USD | 687,500,000USD | 572,600,000USD | 627,700,000USD | 622,100,000USD |
| Cost Of Revenue | 23,200,000USD | 13,800,000USD | 17,600,000USD | 14,000,000USD | 11,300,000USD | 9,200,000USD | 9,300,000USD | 8,000,000USD |
| Gross Profit | 935,800,000USD | 800,700,000USD | 787,900,000USD | 780,900,000USD | 676,200,000USD | 563,400,000USD | 618,400,000USD | 614,100,000USD |
| Research Development | 326,700,000USD | 296,200,000USD | 258,200,000USD | 250,000,000USD | 244,300,000USD | 263,200,000USD | 185,600,000USD | 195,000,000USD |
| Selling General Administrative | 439,700,000USD | 318,500,000USD | 301,800,000USD | 291,600,000USD | 286,300,000USD | 276,500,000USD | 287,800,000USD | 234,300,000USD |
| Total Operating Expenses | 784,300,000USD | 614,700,000USD | 577,000,000USD | 541,900,000USD | 530,600,000USD | 539,800,000USD | 476,400,000USD | 430,300,000USD |
| Operating Income | 151,500,000USD | 186,000,000USD | 210,900,000USD | 239,000,000USD | 145,600,000USD | 23,600,000USD | 142,000,000USD | 183,800,000USD |
| Total Other Income Expense Net | 10,700,000USD | 60,800,000USD | 28,500,000USD | 52,800,000USD | 13,900,000USD | -8,900,000USD | 20,600,000USD | 6,500,000USD |
| Interest Expense | 2,900,000USD | — | — | — | — | — | — | — |
| Income Before Tax | 162,200,000USD | 246,800,000USD | 239,400,000USD | 291,800,000USD | 159,500,000USD | 14,700,000USD | 162,600,000USD | 190,300,000USD |
| Income Tax Expense | 17,800,000USD | 48,900,000USD | 85,700,000USD | 82,300,000USD | 52,000,000USD | 6,800,000USD | 59,500,000USD | 60,500,000USD |
| Net Income | 144,400,000USD | 197,900,000USD | 153,700,000USD | 209,500,000USD | 107,500,000USD | 7,900,000USD | 103,100,000USD | 129,800,000USD |
| Net Income Applicable To Common Shares | 144,400,000USD | — | — | — | — | — | — | — |
| Tax Provision | — | 48,900,000USD | 85,700,000USD | 82,300,000USD | 52,000,000USD | 6,800,000USD | 59,500,000USD | 60,500,000USD |
| Net Income From Continuing Ops | — | 197,900,000USD | 153,700,000USD | 209,500,000USD | 107,500,000USD | 7,900,000USD | 103,100,000USD | 129,800,000USD |
| Ebit | — | 246,800,000USD | 227,900,000USD | 291,800,000USD | 159,500,000USD | 23,700,000USD | 174,600,000USD | 184,800,000USD |
| Ebitda | — | 254,100,000USD | 235,400,000USD | 299,500,000USD | 166,800,000USD | 31,300,000USD | 181,700,000USD | 191,300,000USD |
| Depreciation And Amortization | — | 7,300,000USD | 7,500,000USD | 7,700,000USD | 7,300,000USD | 7,600,000USD | 7,100,000USD | 6,500,000USD |
| Reconciled Depreciation | — | 7,300,000USD | 7,500,000USD | 7,700,000USD | 7,300,000USD | 7,600,000USD | 7,100,000USD | 6,500,000USD |
| Unclassified Operating Expenses | — | — | 17,000,000USD | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,860,500,000USD | 2,355,300,000USD | 1,887,100,000USD | 1,488,700,000USD | 1,133,500,000USD | 1,045,900,000USD | 788,100,000USD | 451,240,000USD |
| Cost Of Revenue | 52,100,000USD | 34,000,000USD | 39,700,000USD | 23,200,000USD | 14,300,000USD | 10,100,000USD | 7,400,000USD | 4,889,000USD |
| Gross Profit | 2,808,400,000USD | 2,321,300,000USD | 1,847,400,000USD | 1,465,500,000USD | 1,119,200,000USD | 1,035,800,000USD | 780,700,000USD | 446,351,000USD |
| Research Development | 1,015,700,000USD | 731,100,000USD | 565,000,000USD | 463,800,000USD | 328,100,000USD | 275,000,000USD | 200,000,000USD | 160,524,000USD |
| Selling General Administrative | 1,156,200,000USD | 816,200,000USD | 851,600,000USD | 752,700,000USD | 583,300,000USD | 433,300,000USD | 354,062,000USD | 248,932,000USD |
| Total Operating Expenses | 2,189,300,000USD | 1,750,800,000USD | 1,596,500,000USD | 1,216,500,000USD | 1,016,700,000USD | 872,800,000USD | 708,400,000USD | 409,456,000USD |
| Operating Income | 619,100,000USD | 570,500,000USD | 250,900,000USD | 249,000,000USD | 102,500,000USD | 163,000,000USD | 72,300,000USD | 36,895,000USD |
| Interest Income | 90,300,000USD | 91,000,000USD | 52,800,000USD | 4,100,000USD | — | — | 25,741,000USD | 15,054,000USD |
| Net Interest Income | 90,300,000USD | 91,000,000USD | -4,600,000USD | -7,100,000USD | -25,800,000USD | -32,800,000USD | -31,963,000USD | -30,530,000USD |
| Income Before Tax | 705,400,000USD | 486,000,000USD | 332,100,000USD | 213,900,000USD | 101,400,000USD | 106,700,000USD | 46,500,000USD | 21,841,000USD |
| Income Tax Expense | 226,800,000USD | 144,700,000USD | 82,400,000USD | 59,400,000USD | 11,800,000USD | -300,600,000USD | 9,500,000USD | 730,000USD |
| Tax Provision | 226,800,000USD | 144,700,000USD | 60,800,000USD | 59,400,000USD | 11,800,000USD | -300,600,000USD | 9,530,000USD | 730,000USD |
| Net Income | 478,600,000USD | 341,300,000USD | 249,700,000USD | 154,500,000USD | 89,600,000USD | 407,300,000USD | 37,000,000USD | 21,111,000USD |
| Net Income From Continuing Ops | 478,600,000USD | 341,300,000USD | 191,000,000USD | 154,500,000USD | 89,600,000USD | 407,300,000USD | 37,012,000USD | 21,111,000USD |
| Ebit | 636,500,000USD | 612,600,000USD | 394,800,000USD | 249,000,000USD | 127,200,000USD | 139,500,000USD | 78,448,000USD | 36,895,000USD |
| Ebitda | 666,600,000USD | 639,700,000USD | 416,100,000USD | 264,600,000USD | 138,100,000USD | 148,100,000USD | 85,900,000USD | 40,919,000USD |
| Depreciation And Amortization | 30,100,000USD | 27,100,000USD | 21,300,000USD | 15,600,000USD | 10,900,000USD | 8,600,000USD | 7,452,000USD | 4,024,000USD |
| Reconciled Depreciation | 30,100,000USD | 27,100,000USD | 20,000,000USD | 15,600,000USD | 10,900,000USD | 8,600,000USD | 7,452,000USD | 4,024,000USD |
| Total Other Income Expense Net | 86,300,000USD | -84,500,000USD | 81,200,000USD | -35,100,000USD | -1,100,000USD | -56,300,000USD | -25,800,000USD | 15,476,000USD |
| Selling And Marketing Expenses | — | 191,000,000USD | — | — | — | — | — | — |
| Interest Expense | — | 126,600,000USD | 4,600,000USD | 7,100,000USD | 25,800,000USD | 32,800,000USD | 32,000,000USD | 30,530,000USD |
| Unclassified Operating Expenses | — | — | 179,900,000USD | — | 105,300,000USD | 164,500,000USD | 154,338,000USD | — |
| Non Operating Income Net Other | — | — | — | -28,000,000USD | 24,700,000USD | -23,500,000USD | 6,222,000USD | 15,476,000USD |
| Net Income Applicable To Common Shares | — | — | — | 154,500,000USD | 89,600,000USD | 407,300,000USD | 37,012,000USD | 21,111,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,359,100,000USD | 4,906,200,000USD | 4,631,500,000USD | 4,265,700,000USD | 3,889,800,000USD | 3,687,700,000USD | 3,718,700,000USD | 3,535,000,000USD |
| Cash And Equivalents | 332,400,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 1,637,500,000USD | 2,436,100,000USD | 2,522,700,000USD | 2,158,400,000USD | 1,748,900,000USD | 1,637,900,000USD | 1,724,700,000USD | 1,876,600,000USD |
| Other Current Assets | 39,400,000USD | 287,300,000USD | 286,500,000USD | 246,300,000USD | 120,700,000USD | 119,300,000USD | 112,100,000USD | 121,700,000USD |
| Other Non Current Assets | 59,300,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 1,665,500,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 874,500,000USD | 831,700,000USD | 743,400,000USD | 638,000,000USD | 546,300,000USD | 522,900,000USD | 507,700,000USD | 429,700,000USD |
| Other Current Liabilities | 66,200,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 297,700,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 3,693,600,000USD | 3,407,400,000USD | 3,253,100,000USD | 3,003,600,000USD | 2,694,300,000USD | 2,535,700,000USD | 2,589,700,000USD | 2,718,900,000USD |
| Total Equity Including Noncontrolling Interest | 3,693,600,000USD | — | — | — | — | — | — | — |
| Net Receivables | 887,000,000USD | 768,100,000USD | 686,800,000USD | 728,000,000USD | 595,700,000USD | 516,000,000USD | 479,100,000USD | 481,100,000USD |
| Inventory | 104,200,000USD | 64,500,000USD | 69,000,000USD | 69,300,000USD | 56,900,000USD | 59,100,000USD | 57,400,000USD | 45,800,000USD |
| Property Plant Equipment Net | 538,500,000USD | 538,000,000USD | 545,200,000USD | 566,200,000USD | 584,000,000USD | 589,200,000USD | 592,000,000USD | 337,300,000USD |
| Goodwill | 500,600,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 2,226,000,000USD | — | — | 35,700,000USD | 37,200,000USD | 36,400,000USD | 36,500,000USD | 34,500,000USD |
| Accounts Payable | 808,300,000USD | 120,000,000USD | 104,900,000USD | 119,900,000USD | 104,600,000USD | 110,000,000USD | 110,000,000USD | 95,700,000USD |
| Short Term Debt | 59,800,000USD | — | — | 51,300,000USD | — | — | — | 34,800,000USD |
| Common Stock | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD |
| Retained Earnings | 724,000,000USD | 589,600,000USD | 447,700,000USD | 294,000,000USD | 84,500,000USD | -5,300,000USD | 29,200,000USD | 81,100,000USD |
| Accumulated Other Comprehensive Income | 5,100,000USD | 400,000USD | 13,100,000USD | 13,200,000USD | 12,500,000USD | 9,000,000USD | 5,800,000USD | 14,500,000USD |
| Total Liab | — | 1,498,800,000USD | 1,378,400,000USD | 1,262,100,000USD | 1,195,500,000USD | 1,152,000,000USD | 1,129,000,000USD | 816,100,000USD |
| Other Current Liab | — | 831,700,000USD | 570,500,000USD | 466,800,000USD | 416,000,000USD | 412,900,000USD | 397,700,000USD | 334,000,000USD |
| Capital Stock | — | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD |
| Cash | — | 266,500,000USD | 713,000,000USD | 340,200,000USD | 264,000,000USD | 194,100,000USD | 233,000,000USD | 349,100,000USD |
| Cash And Short Term Investments | — | 1,316,200,000USD | 1,480,400,000USD | 1,114,800,000USD | 975,600,000USD | 943,500,000USD | 1,076,100,000USD | 1,228,000,000USD |
| Net Debt | — | 139,700,000USD | -297,700,000USD | 567,900,000USD | 175,100,000USD | 253,400,000USD | 222,100,000USD | -97,700,000USD |
| Short Long Term Debt Total | — | 406,200,000USD | 415,300,000USD | 908,100,000USD | 439,100,000USD | 447,500,000USD | 455,100,000USD | 251,400,000USD |
| Long Term Investments | — | 1,477,100,000USD | 1,183,800,000USD | 1,116,600,000USD | 961,300,000USD | 909,500,000USD | 864,300,000USD | 770,600,000USD |
| Short Term Investments | — | 1,049,700,000USD | 767,400,000USD | 774,600,000USD | 711,600,000USD | 749,400,000USD | 843,100,000USD | 878,900,000USD |
| Property Plant Equipment Gross | — | 538,000,000USD | 663,500,000USD | 566,200,000USD | 584,000,000USD | 589,200,000USD | 698,500,000USD | 337,300,000USD |
| Common Stock Shares Outstanding | — | 103,400,000shares | 102,500,000shares | 102,500,000shares | 101,000,000shares | 102,500,000shares | 102,900,000shares | 104,300,000shares |
| Non Current Assets Total | — | 2,470,100,000USD | 2,108,800,000USD | 2,107,300,000USD | 2,140,900,000USD | 2,049,800,000USD | 1,994,000,000USD | 1,658,400,000USD |
| Non Current Liabilities Total | — | 667,100,000USD | 635,000,000USD | 624,100,000USD | 649,200,000USD | 629,100,000USD | 621,300,000USD | 386,400,000USD |
| Non Current Liabilities Other | — | 19,600,000USD | 5,200,000USD | 200,000USD | 27,100,000USD | 15,600,000USD | 5,500,000USD | 100,000USD |
| Non Currrent Assets Other | — | 1,404,600,000USD | 59,500,000USD | 1,018,800,000USD | 21,600,000USD | 15,300,000USD | 15,500,000USD | 61,600,000USD |
| Net Working Capital | — | 1,604,400,000USD | 1,779,300,000USD | 1,520,400,000USD | 1,202,600,000USD | 1,115,000,000USD | 1,217,000,000USD | 1,446,900,000USD |
| Unclassified Non Current Assets | — | -949,600,000USD | 320,300,000USD | -630,000,000USD | 536,800,000USD | 499,400,000USD | 482,000,000USD | 448,300,000USD |
| Unclassified Current Liabilities | — | -120,000,000USD | 68,000,000USD | — | 25,700,000USD | — | — | -81,000,000USD |
| Unclassified Non Current Liabilities | — | 647,500,000USD | 629,800,000USD | 623,900,000USD | 622,100,000USD | 613,500,000USD | 615,800,000USD | 386,300,000USD |
| Unclassified Equity | — | 2,817,200,000USD | 2,792,100,000USD | 2,696,200,000USD | 2,597,100,000USD | 2,531,800,000USD | 2,554,500,000USD | 2,623,100,000USD |
| Good Will | — | — | — | — | — | — | 3,700,000USD | 6,100,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 46,200,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4,631,500,000USD | 3,718,700,000USD | 3,251,400,000USD | 2,368,700,000USD | 2,072,500,000USD | 1,734,700,000USD | 1,306,000,000USD | 993,151,000USD |
| Other Current Assets | 286,500,000USD | 112,100,000USD | 97,800,000USD | 79,100,000USD | 45,500,000USD | 30,100,000USD | 160,500,000USD | 86,864,000USD |
| Total Liab | 1,378,400,000USD | 1,129,000,000USD | 1,019,400,000USD | 660,900,000USD | 698,500,000USD | 608,500,000USD | 669,100,000USD | 512,386,000USD |
| Total Stockholder Equity | 3,253,100,000USD | 2,589,700,000USD | 2,232,000,000USD | 1,707,800,000USD | 1,374,000,000USD | 1,126,200,000USD | 636,900,000USD | 480,765,000USD |
| Other Current Liab | 638,500,000USD | 397,700,000USD | 327,000,000USD | 292,000,000USD | 194,300,000USD | 147,100,000USD | 156,500,000USD | 1,856,000USD |
| Common Stock | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 92,000USD | 91,000USD |
| Capital Stock | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 92,000USD | 91,000USD |
| Retained Earnings | 447,700,000USD | 29,200,000USD | -157,100,000USD | -406,800,000USD | -635,800,000USD | -725,400,000USD | -1,132,700,000USD | -1,177,755,000USD |
| Cash | 713,000,000USD | 233,000,000USD | 251,100,000USD | 262,900,000USD | 340,800,000USD | 187,100,000USD | 112,279,000USD | 141,714,000USD |
| Cash And Short Term Investments | 1,480,400,000USD | 1,076,100,000USD | 1,031,600,000USD | 989,300,000USD | 711,300,000USD | 801,000,000USD | 670,500,000USD | 650,913,000USD |
| Total Current Assets | 2,522,700,000USD | 1,724,700,000USD | 1,607,000,000USD | 1,453,500,000USD | 972,800,000USD | 1,016,200,000USD | 831,000,000USD | 737,777,000USD |
| Total Current Liabilities | 743,400,000USD | 507,700,000USD | 654,800,000USD | 537,700,000USD | 245,800,000USD | 186,500,000USD | 565,300,000USD | 88,233,000USD |
| Net Debt | -297,700,000USD | 222,100,000USD | 177,300,000USD | 169,400,000USD | 99,600,000USD | 225,200,000USD | 383,221,000USD | 246,782,000USD |
| Short Long Term Debt Total | 415,300,000USD | 455,100,000USD | 428,400,000USD | 262,900,000USD | 440,400,000USD | 412,300,000USD | 817,607,000USD | 450,841,000USD |
| Long Term Investments | 1,183,800,000USD | 864,300,000USD | 849,400,000USD | 401,500,000USD | 560,700,000USD | 227,100,000USD | 299,654,000USD | 216,028,000USD |
| Short Term Investments | 767,400,000USD | 843,100,000USD | 780,500,000USD | 726,400,000USD | 370,500,000USD | 613,900,000USD | 558,245,000USD | 509,199,000USD |
| Net Receivables | 686,800,000USD | 479,100,000USD | 439,300,000USD | 350,000,000USD | 185,500,000USD | 157,100,000USD | 126,575,000USD | 56,240,000USD |
| Inventory | 69,000,000USD | 57,400,000USD | 38,300,000USD | 35,100,000USD | 30,500,000USD | 28,000,000USD | 17,288,000USD | 10,864,000USD |
| Accounts Payable | 104,900,000USD | 110,000,000USD | 133,300,000USD | 67,300,000USD | 51,500,000USD | 39,400,000USD | 46,214,000USD | 13,801,000USD |
| Property Plant Equipment Net | 545,200,000USD | 592,000,000USD | 347,300,000USD | 145,600,000USD | 155,800,000USD | 127,400,000USD | 116,200,000USD | 33,869,000USD |
| Property Plant Equipment Gross | 663,500,000USD | 698,500,000USD | 430,300,000USD | 145,600,000USD | 155,800,000USD | 127,400,000USD | 116,278,000USD | 33,869,000USD |
| Accumulated Other Comprehensive Income | 13,100,000USD | 5,800,000USD | 7,000,000USD | -7,900,000USD | -1,700,000USD | 1,800,000USD | 1,413,000USD | -1,932,000USD |
| Common Stock Shares Outstanding | 102,500,000shares | 103,700,000shares | 101,000,000shares | 98,900,000shares | 97,900,000shares | 97,800,000shares | 95,732,000shares | 95,400,000shares |
| Non Current Assets Total | 2,108,800,000USD | 1,994,000,000USD | 1,644,400,000USD | 915,200,000USD | 1,099,700,000USD | 718,500,000USD | 475,000,000USD | 255,374,000USD |
| Non Current Liabilities Total | 635,000,000USD | 621,300,000USD | 364,600,000USD | 123,200,000USD | 452,700,000USD | 422,000,000USD | 103,800,000USD | 424,153,000USD |
| Non Current Liabilities Other | 5,200,000USD | 5,500,000USD | 10,300,000USD | 29,700,000USD | 117,600,000USD | 104,100,000USD | 103,830,000USD | 35,657,000USD |
| Non Currrent Assets Other | 59,500,000USD | 9,800,000USD | 49,600,000USD | 25,000,000USD | 4,400,000USD | 6,400,000USD | 3,200,000USD | 5,477,000USD |
| Net Working Capital | 1,779,300,000USD | 1,217,000,000USD | 952,200,000USD | 915,800,000USD | 727,000,000USD | 829,700,000USD | 265,747,000USD | 649,544,000USD |
| Unclassified Non Current Assets | 320,300,000USD | 485,700,000USD | 356,800,000USD | -30,400,000USD | 59,300,000USD | -316,400,000USD | -15,588,000USD | -16,629,000USD |
| Unclassified Non Current Liabilities | 629,800,000USD | 615,800,000USD | 354,300,000USD | 63,800,000USD | -12,300,000USD | -9,700,000USD | -425,911,000USD | -71,314,000USD |
| Unclassified Equity | 2,792,100,000USD | 2,554,500,000USD | 2,381,900,000USD | 2,122,300,000USD | 2,011,300,000USD | 1,849,600,000USD | 1,768,003,000USD | 1,660,270,000USD |
| Intangible Assets | — | 36,500,000USD | 35,500,000USD | 37,200,000USD | — | — | 12,460,000USD | 11,152,000USD |
| Good Will | — | 5,700,000USD | 5,800,000USD | 5,400,000USD | — | — | — | — |
| Current Deferred Revenue | — | — | 229,300,000USD | — | -16,500,000USD | -10,300,000USD | -46,214,000USD | 10,231,000USD |
| Short Term Debt | — | — | 170,100,000USD | 169,400,000USD | 16,500,000USD | 10,300,000USD | 408,800,000USD | 62,345,000USD |
| Short Long Term Debt | — | — | 170,100,000USD | 169,400,000USD | — | — | 408,807,000USD | 88,233,000USD |
| Unclassified Current Liabilities | — | — | -375,000,000USD | -160,400,000USD | -16,500,000USD | -10,300,000USD | -455,021,000USD | -88,233,000USD |
| Other Liab | — | — | — | 29,700,000USD | 12,300,000USD | 9,700,000USD | 17,074,000USD | 35,657,000USD |
| Other Assets | — | — | — | 330,900,000USD | 319,500,000USD | 674,000,000USD | 59,074,000USD | 5,477,000USD |
| Net Tangible Assets | — | — | — | 1,670,600,000USD | 1,374,000,000USD | 1,126,200,000USD | 228,116,000USD | 480,765,000USD |
| Long Term Debt | — | — | — | — | 335,100,000USD | 317,900,000USD | 408,807,000USD | 388,496,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | -143,887,000USD | -67,104,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 35,657,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 32,100,000USD |
| Stock Based Compensation | 122,200,000USD |
| Deferred Income Tax | -86,400,000USD |
| Change To Account Receivables | -165,700,000USD |
| Change To Inventory | -2,200,000USD |
| Change To Liabilities | -22,800,000USD |
| Change In Working Capital | -190,700,000USD |
| Operating Cash Flow | 282,200,000USD |
| Capital Expenditures | -16,900,000USD |
| Net Investments | 1,670,600,000USD |
| Other Investing Activities | -2,358,500,000USD |
| Unclassified Investing Cash Flow | 63,200,000USD |
| Investing Cash Flow | -641,600,000USD |
| Net Common Stock Issuance | -124,400,000USD |
| Unclassified Financing Cash Flow | 101,700,000USD |
| Financing Cash Flow | -22,700,000USD |
| Effect Of Forex Changes On Cash | 0USD |
| Change In Cash | -382,100,000USD |
| End Cash Flow | 338,900,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 197,900,000USD | 153,700,000USD | 209,500,000USD | 107,500,000USD | 7,900,000USD | 103,100,000USD | 129,800,000USD | 65,000,000USD |
| Depreciation | 7,300,000USD | 7,500,000USD | 7,700,000USD | 7,300,000USD | 7,600,000USD | 7,100,000USD | 6,500,000USD | 7,300,000USD |
| Stock Based Compensation | 57,200,000USD | 58,600,000USD | 53,700,000USD | 52,800,000USD | 52,800,000USD | 66,400,000USD | 41,500,000USD | 43,100,000USD |
| Other Non Cash Items | -52,500,000USD | 1,200,000USD | -274,500,000USD | 10,900,000USD | 33,900,000USD | 2,900,000USD | 10,700,000USD | 76,800,000USD |
| Change To Account Receivables | -81,400,000USD | 38,400,000USD | -132,300,000USD | -79,700,000USD | -36,900,000USD | 2,000,000USD | -12,900,000USD | -17,600,000USD |
| Change To Inventory | 4,300,000USD | -3,400,000USD | -12,300,000USD | 2,100,000USD | -1,700,000USD | -11,600,000USD | -3,300,000USD | -5,300,000USD |
| Change In Working Capital | -3,000,000USD | 119,200,000USD | 62,800,000USD | -39,100,000USD | -23,700,000USD | 94,300,000USD | 4,400,000USD | -86,300,000USD |
| Total Cash From Operating Activities | 145,800,000USD | 388,400,000USD | 227,500,000USD | 102,000,000USD | 64,800,000USD | 242,500,000USD | 158,000,000USD | 64,600,000USD |
| Capital Expenditures | -9,100,000USD | 2,400,000USD | -13,200,000USD | -12,500,000USD | -10,700,000USD | -7,300,000USD | -8,100,000USD | -11,600,000USD |
| Free Cash Flow | 136,700,000USD | 390,800,000USD | 214,300,000USD | 89,500,000USD | 54,100,000USD | 235,200,000USD | 149,900,000USD | 53,000,000USD |
| Investments | -560,300,000USD | -55,300,000USD | -196,700,000USD | -29,000,000USD | 14,200,000USD | -68,300,000USD | 24,700,000USD | -28,200,000USD |
| Total Cashflows From Investing Activities | -506,200,000USD | -52,900,000USD | -196,700,000USD | -29,000,000USD | 14,200,000USD | -68,300,000USD | 24,700,000USD | -28,200,000USD |
| Total Cash From Financing Activities | -86,100,000USD | 37,300,000USD | 45,600,000USD | -3,300,000USD | -117,900,000USD | -290,000,000USD | 26,400,000USD | -293,000,000USD |
| Sale Purchase Of Stock | -109,700,000USD | 0USD | 0USD | -17,700,000USD | -150,000,000USD | -300,000,000USD | — | 0USD |
| Change In Cash | -446,500,000USD | 372,800,000USD | 76,200,000USD | 69,900,000USD | -38,900,000USD | -116,100,000USD | 209,400,000USD | -256,600,000USD |
| Begin Period Cash Flow | 721,000,000USD | 348,200,000USD | 272,000,000USD | 202,100,000USD | 241,000,000USD | 357,100,000USD | 147,700,000USD | 404,300,000USD |
| End Period Cash Flow | 274,500,000USD | 721,000,000USD | 348,200,000USD | 272,000,000USD | 202,100,000USD | 241,000,000USD | 357,100,000USD | 147,700,000USD |
| Other Cashflows From Investing Activities | 63,200,000USD | — | — | — | — | — | — | -16,600,000USD |
| Other Cashflows From Financing Activities | -86,100,000USD | — | — | — | -117,900,000USD | -290,000,000USD | 26,400,000USD | -308,800,000USD |
| Unclassified Operating Cash Flow | -61,100,000USD | 48,200,000USD | 168,300,000USD | -37,400,000USD | -13,700,000USD | -31,300,000USD | -34,900,000USD | -41,300,000USD |
| Unclassified Financing Cash Flow | 109,700,000USD | 37,300,000USD | 45,600,000USD | 14,400,000USD | 150,000,000USD | 300,000,000USD | — | 15,800,000USD |
| Net Borrowings | — | 0USD | 0USD | — | — | 0USD | 0USD | — |
| Unclassified Investing Cash Flow | — | — | 13,200,000USD | 12,500,000USD | 10,700,000USD | 7,300,000USD | 8,100,000USD | 28,200,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 478,600,000USD | 341,300,000USD | 249,700,000USD | 154,500,000USD | 89,600,000USD | 407,300,000USD | 37,000,000USD | 21,100,000USD |
| Depreciation | 30,100,000USD | 27,100,000USD | 21,300,000USD | 15,600,000USD | 10,900,000USD | 8,600,000USD | 7,400,000USD | 4,000,000USD |
| Stock Based Compensation | 217,900,000USD | 195,500,000USD | 194,300,000USD | 173,100,000USD | 134,200,000USD | 100,000,000USD | 75,300,000USD | 58,100,000USD |
| Other Non Cash Items | 19,500,000USD | 173,800,000USD | -46,900,000USD | 44,500,000USD | 800,000USD | 61,200,000USD | 32,100,000USD | 19,900,000USD |
| Change To Account Receivables | -210,500,000USD | -39,800,000USD | -89,300,000USD | -162,200,000USD | -28,400,000USD | -30,500,000USD | -69,200,000USD | -25,100,000USD |
| Change To Inventory | -15,300,000USD | -19,100,000USD | 5,400,000USD | -2,600,000USD | -2,500,000USD | -10,700,000USD | -6,400,000USD | -3,500,000USD |
| Change In Working Capital | -128,800,000USD | -19,200,000USD | 28,200,000USD | -67,400,000USD | 16,700,000USD | -37,900,000USD | -4,800,000USD | -1,700,000USD |
| Total Cash From Operating Activities | 782,700,000USD | 595,400,000USD | 389,900,000USD | 339,400,000USD | 256,500,000USD | 228,500,000USD | 147,000,000USD | 101,400,000USD |
| Capital Expenditures | -34,000,000USD | -38,200,000USD | -28,300,000USD | -16,500,000USD | -23,400,000USD | -10,900,000USD | -14,700,000USD | -24,800,000USD |
| Free Cash Flow | 748,700,000USD | 557,200,000USD | 361,600,000USD | 322,900,000USD | 233,100,000USD | 217,600,000USD | 132,300,000USD | 76,600,000USD |
| Investments | -230,400,000USD | -126,800,000USD | -380,900,000USD | -110,200,000USD | -102,200,000USD | 15,000,000USD | -127,478,000USD | -218,137,000USD |
| Total Cashflows From Investing Activities | -264,399,999USD | -126,800,000USD | -467,100,000USD | -177,100,000USD | -130,200,000USD | 4,100,000USD | -211,100,000USD | -242,900,000USD |
| Net Borrowings | 0USD | -308,800,000USD | 0USD | -279,000,000USD | -100,000USD | -186,900,000USD | -186,900,000USD | -186,900,000USD |
| Total Cash From Financing Activities | -38,300,000USD | -486,700,000USD | 65,300,000USD | -234,300,000USD | 27,400,000USD | -157,800,000USD | 32,400,000USD | 29,500,000USD |
| Sale Purchase Of Stock | -167,700,000USD | -300,000,000USD | 0USD | 44,700,000USD | 27,500,000USD | 29,100,000USD | 27,313,000USD | 29,530,000USD |
| Change In Cash | 480,000,000USD | -18,100,000USD | -11,600,000USD | -73,300,000USD | 153,700,000USD | 74,800,000USD | -31,700,000USD | -112,000,000USD |
| Begin Period Cash Flow | 241,000,000USD | 259,100,000USD | 270,700,000USD | 344,000,000USD | 190,300,000USD | 115,500,000USD | 147,200,000USD | 259,200,000USD |
| End Period Cash Flow | 721,000,000USD | 241,000,000USD | 259,100,000USD | 270,700,000USD | 344,000,000USD | 190,300,000USD | 115,500,000USD | 147,200,000USD |
| Other Cashflows From Financing Activities | -38,300,000USD | 122,100,000USD | 65,300,000USD | -177,100,000USD | 27,500,000USD | 4,100,000USD | 5,087,000USD | -30,000USD |
| Unclassified Operating Cash Flow | 165,400,000USD | -123,100,000USD | -56,700,000USD | 19,100,000USD | 4,300,000USD | -310,700,000USD | — | — |
| Unclassified Financing Cash Flow | 167,700,000USD | — | — | 177,100,000USD | -27,500,000USD | -4,100,000USD | 186,900,000USD | 186,900,000USD |
| Other Cashflows From Investing Activities | — | 0USD | — | -117,900,000USD | -4,600,000USD | 15,000,000USD | -68,855,000USD | 34,000USD |
| Unclassified Investing Cash Flow | — | 38,200,000USD | -57,900,000USD | 67,500,000USD | — | -15,000,000USD | — | — |
| Change To Liabilities | — | — | — | 114,600,000USD | 56,800,000USD | 26,900,000USD | 53,955,000USD | 24,223,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -72,000,000USD | 153,700,000USD | 74,800,000USD | -31,706,000USD | -112,021,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 28,913,000USD | 27,313,000USD | 29,530,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Collaboration Revenue | 4,700,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 954,300,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenue | 3,500,000 | USD | 0000914475-26-000026 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 811,000,000 | USD | 0000914475-26-000026 |
| Q4 2025Quarterly · 2025-12-31 | Product | Collaboration Revenue | 7,200,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 798,300,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Collaboration Revenue | 26,600,000 | USD | 0000914475-26-000007 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 2,833,900,000 | USD | 0000914475-26-000007 |
| Q3 2025Quarterly · 2025-09-30 | Product | Collaboration Revenue | 5,000,000 | USD | 0000914475-25-000181 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 789,900,000 | USD | 0000914475-25-000181 |
| Q2 2025Quarterly · 2025-06-30 | Product | Collaboration Revenue | 5,500,000 | USD | 0000914475-25-000158 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 682,000,000 | USD | 0000914475-25-000158 |
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration Revenue | 8,900,000 | USD | 0000914475-26-000026 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 563,700,000 | USD | 0000914475-26-000026 |
| FY 2024Yearly · 2024-12-31 | Product | Collaboration Revenue | 24,700,000 | USD | 0000914475-25-000037 |
| FY 2024Yearly · 2024-12-31 | Product | INGREZZA | 2,300,000,000 | USD | 0000914475-25-000037 |
| FY 2024Yearly · 2024-12-31 | Product | Other | 17,100,000 | USD | 0000914475-25-000037 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty | 13,500,000 | USD | 0000914475-25-000037 |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaboration Revenue | 5,500,000 | USD | 0000914475-24-000211 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 616,600,000 | USD | 0000914475-24-000211 |
| Q3 2024Quarterly · 2024-09-30 | Product | Royalty | 3,300,000 | USD | 0000914475-24-000211 |
| Q2 2024Quarterly · 2024-06-30 | Product | Collaboration Revenue | 6,400,000 | USD | 0000914475-24-000181 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 583,800,000 | USD | 0000914475-24-000181 |
| Q2 2024Quarterly · 2024-06-30 | Product | Royalty | 3,500,000 | USD | 0000914475-24-000181 |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration Revenue | 26,500,000 | USD | 0000914475-24-000054 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 1,860,600,000 | USD | 0000914475-24-000054 |
| FY 2023Yearly · 2023-12-31 | Product | Royalty | 16,700,000 | USD | 0000914475-24-000054 |
| FY 2019Yearly · 2019-12-31 | Product | Collaboration Revenue | 35,187,000 | USD | 0001564590-20-003773 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 752,900,000 | USD | 0001564590-20-003773 |
| FY 2018Yearly · 2018-12-31 | Product | Collaboration Revenue | 41,600,000 | USD | 0000914475-21-000020 |
| FY 2018Yearly · 2018-12-31 | Product | Product | 409,600,000 | USD | 0000914475-21-000020 |
| FY 2018Yearly · 2018-12-31 | Product | Royalty | 1,600,000 | USD | 0000914475-21-000020 |
| FY 2017Yearly · 2017-12-31 | Product | Collaboration Revenue | 45,000,000 | USD | 0001564590-20-003773 |
| FY 2017Yearly · 2017-12-31 | Product | Product | 116,626,000 | USD | 0001564590-20-003773 |
| FY 2016Yearly · 2016-12-31 | Product | Collaboration Revenue | 15,000,000 | USD | 0001564590-19-002328 |
| FY 2016Yearly · 2016-12-31 | Product | Product | 0 | USD | 0001564590-19-002328 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.